Microbial cues and T cell immunity: deciphering their interactions in chronic liver disease
- 1NHC Key Laboratory of Digestive Diseases (Renji Hospital, Shanghai Jiao Tong University School of Medicine), Division of Gastroenterology and Hepatology, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong University; Shanghai Institute of Digestive Disease, 145 Middle Shandong Road, Shanghai, 200001 China
Abstract
Chronic liver disease (CLD) poses a major global health challenge, as its progression to cirrhosis and hepatocellular carcinoma significantly contributes to worldwide morbidity and mortality. Mounting evidence has identified the gut microbiota as a critical modulator of CLD progression, primarily via the gut–liver axis. The liver is continuously exposed to gut-derived signals through the portal circulation, while reciprocally secreting bioactive mediators that shape intestinal microbial composition and function. This bidirectional network enables intricate crosstalk between the gut microbiota and the host immune system. In particular, T lymphocytes, the central effectors of adaptive immunity, are tightly regulated by gut microbiota and their metabolites. Conversely, T cells also modulate the gut microbial ecosystem. Herein, we summarize current knowledge on this bidirectional crosstalk, focusing on how gut microbiota shape T cell differentiation, function and plasticity, as well as the reciprocal impact of T cells on the gut microbiota. Furthermore, we evaluate how these interactions influence the development and progression of various CLDs, including autoimmune liver diseases, alcohol-associated liver disease, metabolic dysfunction-associated steatotic liver disease and viral hepatitis. Finally, we discuss the therapeutic potential of targeting gut microbiota–T cell interactions through immunomodulatory and microbiota-directed strategies to offer novel therapeutic approaches.
Related
- Ureic clearance granule ameliorates chronic kidney disease by reshaping microbial dysbiosis via modulating bile acid metabolism
- Deciphering global transcriptional dynamics coordinated by gene-gene regulatory interactions using single-cell data
- Microbial control of mucosal wound immunity in colorectal anastomotic healing: from barrier repair to matrix failure
- From high-salt diet to cancer immunity: gut microbiota and immune system interactions and their mechanisms
- Metabolomics in microbiology: interrogating microbial physiology and interactions
BibTeX
@article{liu2026microbial,
title = {{Microbial cues and T cell immunity: deciphering their interactions in chronic liver disease}},
author = {Yinuo Liu and Baichao Yu and Qiaoyan Liu and Xiong Ma and Ruqi Tang},
journal = {Experimental \& Molecular Medicine},
year = {2026},
month = oct,
doi = {10.1038/s12276-026-01831-y},
url = {https://doi.org/10.1038/s12276-026-01831-y},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Microbial cues and T cell immunity: deciphering their interactions in chronic liver disease
AU - Yinuo Liu
AU - Baichao Yu
AU - Qiaoyan Liu
AU - Xiong Ma
AU - Ruqi Tang
PY - 2026
DA - 2026/10/09
JO - Experimental & Molecular Medicine
DO - 10.1038/s12276-026-01831-y
UR - https://doi.org/10.1038/s12276-026-01831-y
AB - Chronic liver disease (CLD) poses a major global health challenge, as its progression to cirrhosis and hepatocellular carcinoma significantly contributes to worldwide morbidity and mortality. Mounting evidence has identified the gut microbiota as a critical modulator of CLD progression, primarily via the gut–liver axis. The liver is continuously exposed to gut-derived signals through the portal circulation, while reciprocally secreting bioactive mediators that shape intestinal microbial composition and function. This bidirectional network enables intricate crosstalk between the gut microbiota and the host immune system. In particular, T lymphocytes, the central effectors of adaptive immunity, are tightly regulated by gut microbiota and their metabolites. Conversely, T cells also modulate the gut microbial ecosystem. Herein, we summarize current knowledge on this bidirectional crosstalk, focusing on how gut microbiota shape T cell differentiation, function and plasticity, as well as the reciprocal impact of T cells on the gut microbiota. Furthermore, we evaluate how these interactions influence the development and progression of various CLDs, including autoimmune liver diseases, alcohol-associated liver disease, metabolic dysfunction-associated steatotic liver disease and viral hepatitis. Finally, we discuss the therapeutic potential of targeting gut microbiota–T cell interactions through immunomodulatory and microbiota-directed strategies to offer novel therapeutic approaches.
SN - 1226-3613
SN - 2092-6413
ER -